Work

Abstract P1-19-30: Safety results from a phase 2 study of Palbociclib in combination with Tamoxifen as first line therapy for metastatic hormone receptor positive breast cancer

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs19-p1-19-30

Authors: Oana C Danciu, Kent Hoskins, Cristina Truica, Anne Blaes, Deimante Tamkus, Jatin Rana, Tandra Pavankumar, Lauren Green, Li Liu, Menggang Yu, Deborah Toppmeyer, Ruth O'Regan, Kari Wisinski

Institutions: University of Illinois Chicago, Penn State Cancer Institute, University of Minnesota, Michigan State University, Nebraska Medical Center, University of Nebraska Medical Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Rutgers Cancer Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3013662049

Cites:

Cited by:

Related to: 10